Clinical Research Facility
St. Louis Park, Minnesota 55426
We've found
1 trials
at this facility
Clinical Trial
Updated: 12/7/2016
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
Status: Enrolling,
Phase
III
Updated: 12/7/2016
Click here to add this to my saved trials
